Luke Pase

Geçmiş katılımlar

• 11th CAR-TCR Summit 2026

  15–17 Sept 2026Boston, United States of America

  • KonuşmacıEnhancing TCR Design to Advance Targeted Delivery & Clinical Impact
• 8th RAS-Targeted Drug Development Summit

  8–10 Sept 2026Boston, United States of America

  • PanelPanel Discussion: Setting the Boundaries of What’s Clinically Achievable in RAS Therapy Defining the Realistic Therapeutic Window for Next-Generation Strategiesİle: Federico Innocenti, Sai Vemula
  • KonuşmacıDesigning a Library of TCR T Cell Therapy Products that Precisely Target Mutant KRAS

Şu etkinlikteki diğer konuşmacılar: 11th CAR-TCR Summit 2026

• James Adams

  Chief Technical Officer, Tr1x therapeutics

• Stephan Krause

  Executive Director, Analytical Strategy, Cell Therapy Global Quality, Bristol Myers Squibb

• Michael Mingueneau

  Vice President, Immunology, Sail Biomedicines

• Nikhil Mutyal

  Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca

• Daniel Shelly

  Chief Business Development Officer, PolTREG

• Hong Xin

  Senior Director, Oncology Scientific Innovation, Johnson & Johnson

Etkinlik sayfasında 83 konuşmacının tümünü gör

Şu etkinlikteki diğer konuşmacılar: 8th RAS-Targeted Drug Development Summit

• Nagi Ayad

  Professor, Georgetown University

• Stephanie Braun

  Executive Director & Head of Enzalutamide, Medical Affairs (US), Astellas Pharma

• Silvia Coma

  Senior Director, Translational & Preclinical Research, Verastem, inc

• Peter DeMuth

  Chief Scientific Officer, Elicio Therapeutics

• Matthew Farren

  Senior Research, Pharmacology Investigator, Incyte Corporation

• George Fromm

  Chief Scientific Officer, KAYAK

Etkinlik sayfasında 30 konuşmacının tümünü gör